Investigations of Plantago ovata husk Powder as a Disintegrating Agent for Development of Famotidine Tablets
DOI:
https://doi.org/10.37285/ijpsn.2011.4.2.7Abstract
The main objective of this study is to explore development of pharmaceutical excipients from the husk obtained from the seeds of Plantago ovata. Husk shows very good swelling property in water due to the major part of mucilage in it. Since swelling is one of the mechanisms of action of some tablet disintegrants, it is thought that the husk powder of Plantago ovata would be able to act as a tablet disintegrant. The powder obtained from the Plantago ovata husk was characterized for micromeritical properties, swelling capacity, hydration capacity, LOD, pH, particle size, foreign particles, ash value and microbial limit tests. Its disintegrant ability in comparison with maize starch was investigated by preparing famotidine tablets via the direct compression method. It was also compared with three marketed tablets of famotidine. The Plantago ovata husk powder, however, showed superior flow, swelling capacity as well as water retention capacity than maize starch. The tablets were characterized for hardness, friability, weight variation, in vitro disintegration study and in vitro dissolution study. The optimized batch F2C comprising of 10% of the Plantago ovata husk powder showed a 15 seconds disintegration time, which was significantly less than tablets prepared from maize starch as well as all three market preparations. Tablets from batch F2C were submitted for short term stability studies and exhibited stable characteristics.
Downloads
Metrics
Keywords:
Plantago ovata husk, famotidine, disintegration time, maize starch BP, stability study
Downloads
Published
How to Cite
Issue
Section
References
Akbuga J, Gursoy A and Yetimoglu F (1989). Preparation and properties of tablets prepared from Furosemide – PVP solid dispersion systems. Drug Dev Ind Pharm 14: 2091 – 2108.
Antony PJ and Sanghavi NM (1997). A new disintegrant for pharmaceutical dosage forms. Drug Dev Ind Pharm 23: 413 - 415.
Baveja SK and Gupta BM (1968). Rheology of aqueous dispersions of Plantego ovata seed husk‐II. Ind J Pharm Sci 30: 247 ‐ 251.
Bolhuis GK., Vankamp HV, Lerk CK and Sesink FGM (1982). On the mechanism of action of modern disintegrants. Acta Pharm Technol 28: 111 - 114.
Bowen FE and Vadino WA (1984). A simple method for differentiating sources. Drug Dev Ind Pharm 10: 505 – 511.
Caramella C, Colombo P, Conte U, Ferrari F, Gazannagi A, LaManna A and Peppas NA (1988). A physical analysis of the phenomenon of tablet disintegration. Int J Pharm 44: 177 - 186.
Caramella C, Colombo P, Conte U, Ferrari F and LaManna A (1986). Water uptake and disintegration force measurements: Towards a general understanding of disintegration mechanisms. Drug Dev Ind Pharm 12: 1749 – 1766.
Carli F, Colombo I, Simioni L and Bianchini R (1981). The effect of compression on the capillary microstructure of tablets. J Pharm Pharmacol 35: 129 - 135.
Chakraborty S, Khandai M, Singh SP and Patra NC (2008). Comparative study on effect of natural and synthetic superdisintegrants in the formulation of fast dissolving tablets. Int J Green Pharm 2: 22 - 25.
Deveswaran R, Sharon F, Bharath S, Sindhu A, Basavaraj BV and Madhavan V (2010). Evaluation of disintegrant properties of Plantago Ovata mucilage in comparison with other superdisintegrants. Arch Pharm Sci & Res 2: 230 – 235.
Fukuoka E, Kimura S and Yamazaki M (1981). The rate of penetration of liquid into tablets. Chem Pharm Bull 29: 205 – 212.
Ghule BN, Dharwhekar GD, Jain DK and Yeole PG (2006). Evaluation of binding property of eulophia campestris wall mucilage. Ind J Pharm Sci 68: 566 - 569.
Iwuagwu MA and Okoli PC (1992). The disintegrant properties of pregelatinized cassava and white yam starch. Pharm World J 9: 49–53.
Jones TM (1968). Measuring cohesion in particles. Mfg Chem 39: 38– 40.
Kanig JL and Rudnic EM (1984). The mechanism of disintegrant action. Pharm Technol 8: 50 – 62.
Khanna M, Nandi RC, Singh S, Jain GK and Sarin JPS (1988). Standardization of pure isapgol (Plantago ovata) mucilage for pharmaceutical use. Ind J Pharm Sci 50: 238-240.
Kulkarni GT, Gowthamarajan K, Rao BG and Suresh B (2002). Evaluation of binding property of Plantago ovata and Trigonella Foenum gracecum mucilage. Indian Drugs 39: 422 - 425.
Lachman L, Lieberman HA and Kanig JL (1987). The theory and practice of industrial pharmacy. 3rd ed. Varghese Publishing House, Mumbai.
Malayiya R et.al (2010). Mango peel pectin as a superdisintegrating agent. J Sci Ind Res 69: 688 - 690.
Michael J and Pelezar JR (1993). Microbiology. 5th ed. McGraw-Hill Publication, New Delhi.
Paronen P, Juslin M and Kasnanen K (1984). Comparison of xylan and some commercial materials as disintegrants in tablets. Book of proceedings 4th. Pharm. Tech. Conf., Vol. II, April 11th; Univ. of Edinburgh. Scotland; 46–68.
Patel DM, Prajapati DG and Patel NM (2007). Seed Mucilage from Ocimum americanum Linn. as disintegrant in Tablets: Separation and Evaluation. Ind J Pharm Sci 69: 431-435.
Ravikumar et al., (2009). Evaluation of disintegrating properties of Abelmoschus esculentus mucilage. Int J Pharm Tech Res 1: 241 - 246.
Ravikumar, Shirwaikar AA, Shirwaikar A, Prabhu SL and Rajendran MK (2007). Studies of disintegrant properties of seed mucilage of Ocimum gratissium, Ind J Pharm Sci 69: 753 - 756.
Ring SG (1985). Some studies on starch gelation. Starch 37: 80 - 83.
Shangraw R, Mitrejev A and Shah M (1980). A new era of tablet disintegrants. Pharm Technol 4: 49 – 57.
Shirsand SB, Suresh S, Para MS, Swamy PV and Nagendrakumar D (2009). Plantago ovata mucilage in the design of fast disintegrating tablets. Ind J Pharm Sci 71: 41 - 45.
Van Kamp HV, Bolhuis GK, de Boer AH, Lerk CF and Lie-A-Huen L (1986). The role of water uptake on tablet disintegration. Pharm Acta Helv 1: 1 – 8.
Washi SP, Sharma VD, Jain VK and Sinha P (1985). Plantago ovate: genetic diversity, cultivation, utilization and chemistery. Indian J Nat Prod 1: 3 - 6.
Yeh KC, Chremos AN, Lin JH, Constanzer ML, Kanovsky SM, Hucker SB, Antonello J, Vlasses P, Ryan JR and Williams RL (2006). Single-dose pharmacokinetics and bioavailability of famotidine in man. Results of multicenter collaborative studies. Biopharm Drug Dispos 8: 549 – 560.
